Page last updated: 2024-12-08

5'-deoxyadenosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5'-deoxyadenosine: main heading DEOXYADENOSINE refers to the 3' cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5'-deoxyadenosine : A 5'-deoxyribonucleoside compound having adenosine as the nucleobase. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439182
CHEMBL ID443485
CHEBI ID17319
SCHEMBL ID542617
MeSH IDM0104474

Synonyms (39)

Synonym
brn 0091536
CHEBI:17319 ,
adenosine, 5'-deoxy-
(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-methyl-tetrahydrofuran-3,4-diol
5ad ,
4754-39-6
C05198
ch3ado
5'-deoxyadenosine
5'-deoxyadenosine, methylthioadenosine/s-adenosylhomocysteine (mta/sah) nucleosidase substrate
5'-doa
adenosine, 5'-deoxy- (6ci,7ci,8ci,9ci)
5?-deoxyadenosine
HMS1661B08
CHEMBL443485
(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-methyloxolane-3,4-diol
A827267
4-26-00-03588 (beilstein handbook reference)
unii-2u0tyc8y5a
2u0tyc8y5a ,
5 inverted exclamation marka-dado
SCHEMBL542617
5''''-deoxyadenosine
bdbm50453915
5''-deoxyadenosine
XGYIMTFOTBMPFP-KQYNXXCUSA-N
(2r,3r,4s,5r)-2-(6-amino-9h-purin-9-yl)-5-methyloxolane-3,4-diol
CCG-244287
5'-deoxy-adenosine
HY-113291
CS-0059534
AKOS030573817
(2r,3r,4s,5r)-2-(6-amino-9h-purin-9-yl)-5-methyltetrahydrofuran-3,4-diol
Q27102319
(2r,3s,4s,5r)-2-(6-aminopurin-9-yl)-5-methyl-oxolane-3,4-diol
79321-11-2
MS-23550
PD098724
DTXSID901036031
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
5'-deoxyribonucleoside
adenosinesAny purine ribonucleoside that is a derivative of adenosine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (64)

PathwayProteinsCompounds
Metabolism14961108
Metabolism of vitamins and cofactors146155
Metabolism of water-soluble vitamins and cofactors102114
Molybdenum cofactor biosynthesis817
Amino acid and derivative metabolism250260
Glyoxylate metabolism and glycine degradation2037
Lipoic Acid Metabolism310
Tyrosine Biosynthesis519
Thiamin Diphosphate Biosynthesis1027
Thiazole Biosynthesis I314
Lipoate Biosynthesis and Incorporation I24
Molybdenum Cofactor Biosynthesis615
Thio-Molybdenum Cofactor Biosynthesis717
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis I011
Metabolism of RNA63740
tRNA processing10729
tRNA modification in the nucleus and cytosol4325
Synthesis of wybutosine at G37 of tRNA(Phe)616
superpathway of thiamine diphosphate biosynthesis III (eukaryotes)324
molybdenum cofactor biosynthesis618
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis211
1,4-dihydroxy-6-naphthoate biosynthesis II714
1,4-dihydroxy-6-naphthoate biosynthesis I817
8-methylmenaquinone biosynthesis25
heme b biosynthesis III (from siroheme)113
heme b biosynthesis II (anaerobic)413
superpathway of heme b biosynthesis from uroporphyrinogen-III517
(aminomethyl)phosphonate degradation1231
superpathway of demethylmenaquinol-6 biosynthesis II619
molybdenum cofactor biosynthesis1823
3,8-divinyl-chlorophyllide a biosynthesis II (anaerobic)934
heme degradation V213
dTDP-D-desosamine biosynthesis1422
paromamine biosynthesis II522
factor 420 biosynthesis522
tetrahydromethanopterin biosynthesis938
FeMo cofactor biosynthesis614
heme d1 biosynthesis412
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis614
superpathway of thiamine diphosphate biosynthesis III (eukaryotes)1225
fosfomycin biosynthesis426
phosalacine biosynthesis2049
phosphinothricin tripeptide biosynthesis1956
glyphosate degradation III718
wybutosine biosynthesis510
methylwyosine biosynthesis59
7-(3-amino-3-carboxypropyl)-wyosine biosynthesis610
superpathway of bacteriochlorophyll a biosynthesis2270
bacteriochlorophyll e biosynthesis642
superpathway of erythromycin biosynthesis1842
superpathway of megalomicin A biosynthesis842
superpathway of menaquinol-8 biosynthesis II524
superpathway of menaquinol-8 biosynthesis III722
methylphosphonate degradation I717
methylphosphonate degradation II116
lipoate biosynthesis and incorporation II211
hopanoid biosynthesis (bacteria)830
5,6-dimethylbenzimidazole biosynthesis II (anaerobic)614
heme biosynthesis from uroporphyrinogen-III II012
heme biosynthesis II (anaerobic)010
superpathway of heme biosynthesis from uroporphyrinogen-III013
biotin biosynthesis from 8-amino-7-oxononanoate I013
heme biosynthesis from uroporphyrinogen-III II (anaerobic)511
biotin biosynthesis from 8-amino-7-oxononanoate212
biotin biosynthesis I315
biotin biosynthesis from 7-keto-8-aminopelargonate012
linezolid resistance05
heme biosynthesis III (from siroheme)110
aminomethylphosphonate degradation419

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Adenosine receptor A1Rattus norvegicus (Norway rat)Ki6.96000.00011.20929.9700AID32352; AID32353
Adenosine receptor A3Rattus norvegicus (Norway rat)Ki2.83000.00030.91969.0000AID33337
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Heat shock cognate 71 kDa proteinHomo sapiens (human)Kd130.91300.26003.05117.0000AID1310291
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
S-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)Km6.00003.10004.67506.0000AID239753
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (58)

Processvia Protein(s)Taxonomy
G1/S transition of mitotic cell cycleHeat shock cognate 71 kDa proteinHomo sapiens (human)
mRNA splicing, via spliceosomeHeat shock cognate 71 kDa proteinHomo sapiens (human)
kidney developmentHeat shock cognate 71 kDa proteinHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein foldingHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein import into nucleusHeat shock cognate 71 kDa proteinHomo sapiens (human)
response to unfolded proteinHeat shock cognate 71 kDa proteinHomo sapiens (human)
skeletal muscle tissue developmentHeat shock cognate 71 kDa proteinHomo sapiens (human)
cellular response to starvationHeat shock cognate 71 kDa proteinHomo sapiens (human)
response to xenobiotic stimulusHeat shock cognate 71 kDa proteinHomo sapiens (human)
response to nickel cationHeat shock cognate 71 kDa proteinHomo sapiens (human)
negative regulation of cardiac muscle cell apoptotic processHeat shock cognate 71 kDa proteinHomo sapiens (human)
response to activityHeat shock cognate 71 kDa proteinHomo sapiens (human)
synaptic vesicle uncoatingHeat shock cognate 71 kDa proteinHomo sapiens (human)
cerebellum developmentHeat shock cognate 71 kDa proteinHomo sapiens (human)
forebrain developmentHeat shock cognate 71 kDa proteinHomo sapiens (human)
regulation of protein stabilityHeat shock cognate 71 kDa proteinHomo sapiens (human)
response to estradiolHeat shock cognate 71 kDa proteinHomo sapiens (human)
response to progesteroneHeat shock cognate 71 kDa proteinHomo sapiens (human)
cellular response to heatHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein refoldingHeat shock cognate 71 kDa proteinHomo sapiens (human)
regulation of protein-containing complex assemblyHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein transmembrane import into intracellular organelleHeat shock cognate 71 kDa proteinHomo sapiens (human)
positive regulation by host of viral genome replicationHeat shock cognate 71 kDa proteinHomo sapiens (human)
estrous cycleHeat shock cognate 71 kDa proteinHomo sapiens (human)
response to ethanolHeat shock cognate 71 kDa proteinHomo sapiens (human)
positive regulation of proteolysisHeat shock cognate 71 kDa proteinHomo sapiens (human)
negative regulation of DNA-templated transcriptionHeat shock cognate 71 kDa proteinHomo sapiens (human)
ATP metabolic processHeat shock cognate 71 kDa proteinHomo sapiens (human)
positive regulation of mRNA splicing, via spliceosomeHeat shock cognate 71 kDa proteinHomo sapiens (human)
positive regulation of phagocytosisHeat shock cognate 71 kDa proteinHomo sapiens (human)
regulation of cell cycleHeat shock cognate 71 kDa proteinHomo sapiens (human)
membrane organizationHeat shock cognate 71 kDa proteinHomo sapiens (human)
regulation of protein complex stabilityHeat shock cognate 71 kDa proteinHomo sapiens (human)
chaperone-mediated autophagyHeat shock cognate 71 kDa proteinHomo sapiens (human)
late endosomal microautophagyHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein targeting to lysosome involved in chaperone-mediated autophagyHeat shock cognate 71 kDa proteinHomo sapiens (human)
cellular response to hydrogen peroxideHeat shock cognate 71 kDa proteinHomo sapiens (human)
cellular response to cadmium ionHeat shock cognate 71 kDa proteinHomo sapiens (human)
cellular response to steroid hormone stimulusHeat shock cognate 71 kDa proteinHomo sapiens (human)
clathrin coat disassemblyHeat shock cognate 71 kDa proteinHomo sapiens (human)
positive regulation of lysosomal membrane permeabilityHeat shock cognate 71 kDa proteinHomo sapiens (human)
maintenance of postsynaptic specialization structureHeat shock cognate 71 kDa proteinHomo sapiens (human)
regulation of postsynapse organizationHeat shock cognate 71 kDa proteinHomo sapiens (human)
negative regulation of NLRP3 inflammasome complex assemblyHeat shock cognate 71 kDa proteinHomo sapiens (human)
negative regulation of supramolecular fiber organizationHeat shock cognate 71 kDa proteinHomo sapiens (human)
regulation of protein importHeat shock cognate 71 kDa proteinHomo sapiens (human)
positive regulation of protein refoldingHeat shock cognate 71 kDa proteinHomo sapiens (human)
chaperone-mediated autophagy translocation complex disassemblyHeat shock cognate 71 kDa proteinHomo sapiens (human)
slow axonal transportHeat shock cognate 71 kDa proteinHomo sapiens (human)
response to odorantHeat shock cognate 71 kDa proteinHomo sapiens (human)
chaperone cofactor-dependent protein refoldingHeat shock cognate 71 kDa proteinHomo sapiens (human)
nicotinamide riboside catabolic processS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
nucleobase-containing compound metabolic processS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
purine ribonucleoside salvageS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
L-methionine salvage from methylthioadenosineS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
methylationS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
response to testosteroneS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (26)

Processvia Protein(s)Taxonomy
G protein-coupled receptor bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
phosphatidylserine bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
RNA bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
ATP bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
ATP hydrolysis activityHeat shock cognate 71 kDa proteinHomo sapiens (human)
enzyme bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
MHC class II protein complex bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein-macromolecule adaptor activityHeat shock cognate 71 kDa proteinHomo sapiens (human)
heat shock protein bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
ubiquitin protein ligase bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
A1 adenosine receptor bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
peptide bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
ADP bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
cadherin bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
unfolded protein bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein-folding chaperone bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
C3HC4-type RING finger domain bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
ATP-dependent protein disaggregase activityHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein carrier chaperoneHeat shock cognate 71 kDa proteinHomo sapiens (human)
ATP-dependent protein folding chaperoneHeat shock cognate 71 kDa proteinHomo sapiens (human)
prostaglandin bindingHeat shock cognate 71 kDa proteinHomo sapiens (human)
clathrin-uncoating ATPase activityHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein folding chaperoneHeat shock cognate 71 kDa proteinHomo sapiens (human)
1,4-alpha-oligoglucan phosphorylase activityS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
protein bindingS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
S-methyl-5-thioadenosine phosphorylase activityS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (43)

Processvia Protein(s)Taxonomy
lysosomal membraneHeat shock cognate 71 kDa proteinHomo sapiens (human)
Prp19 complexHeat shock cognate 71 kDa proteinHomo sapiens (human)
photoreceptor inner segmentHeat shock cognate 71 kDa proteinHomo sapiens (human)
extracellular regionHeat shock cognate 71 kDa proteinHomo sapiens (human)
extracellular spaceHeat shock cognate 71 kDa proteinHomo sapiens (human)
nucleusHeat shock cognate 71 kDa proteinHomo sapiens (human)
nucleoplasmHeat shock cognate 71 kDa proteinHomo sapiens (human)
spliceosomal complexHeat shock cognate 71 kDa proteinHomo sapiens (human)
nucleolusHeat shock cognate 71 kDa proteinHomo sapiens (human)
lysosomal membraneHeat shock cognate 71 kDa proteinHomo sapiens (human)
late endosomeHeat shock cognate 71 kDa proteinHomo sapiens (human)
autophagosomeHeat shock cognate 71 kDa proteinHomo sapiens (human)
cytosolHeat shock cognate 71 kDa proteinHomo sapiens (human)
microtubuleHeat shock cognate 71 kDa proteinHomo sapiens (human)
intermediate filamentHeat shock cognate 71 kDa proteinHomo sapiens (human)
plasma membraneHeat shock cognate 71 kDa proteinHomo sapiens (human)
focal adhesionHeat shock cognate 71 kDa proteinHomo sapiens (human)
synaptic vesicleHeat shock cognate 71 kDa proteinHomo sapiens (human)
cell surfaceHeat shock cognate 71 kDa proteinHomo sapiens (human)
postsynaptic densityHeat shock cognate 71 kDa proteinHomo sapiens (human)
membraneHeat shock cognate 71 kDa proteinHomo sapiens (human)
secretory granule lumenHeat shock cognate 71 kDa proteinHomo sapiens (human)
melanosomeHeat shock cognate 71 kDa proteinHomo sapiens (human)
terminal boutonHeat shock cognate 71 kDa proteinHomo sapiens (human)
dendritic spineHeat shock cognate 71 kDa proteinHomo sapiens (human)
dendritic shaftHeat shock cognate 71 kDa proteinHomo sapiens (human)
lysosomal lumenHeat shock cognate 71 kDa proteinHomo sapiens (human)
perikaryonHeat shock cognate 71 kDa proteinHomo sapiens (human)
perinuclear region of cytoplasmHeat shock cognate 71 kDa proteinHomo sapiens (human)
clathrin-sculpted gamma-aminobutyric acid transport vesicle membraneHeat shock cognate 71 kDa proteinHomo sapiens (human)
extracellular exosomeHeat shock cognate 71 kDa proteinHomo sapiens (human)
blood microparticleHeat shock cognate 71 kDa proteinHomo sapiens (human)
lumenal side of lysosomal membraneHeat shock cognate 71 kDa proteinHomo sapiens (human)
photoreceptor ribbon synapseHeat shock cognate 71 kDa proteinHomo sapiens (human)
glycinergic synapseHeat shock cognate 71 kDa proteinHomo sapiens (human)
glutamatergic synapseHeat shock cognate 71 kDa proteinHomo sapiens (human)
presynaptic cytosolHeat shock cognate 71 kDa proteinHomo sapiens (human)
postsynaptic cytosolHeat shock cognate 71 kDa proteinHomo sapiens (human)
postsynaptic specialization membraneHeat shock cognate 71 kDa proteinHomo sapiens (human)
ficolin-1-rich granule lumenHeat shock cognate 71 kDa proteinHomo sapiens (human)
lysosomal matrixHeat shock cognate 71 kDa proteinHomo sapiens (human)
protein folding chaperone complexHeat shock cognate 71 kDa proteinHomo sapiens (human)
ribonucleoprotein complexHeat shock cognate 71 kDa proteinHomo sapiens (human)
cytosolHeat shock cognate 71 kDa proteinHomo sapiens (human)
plasma membraneHeat shock cognate 71 kDa proteinHomo sapiens (human)
cytoplasmHeat shock cognate 71 kDa proteinHomo sapiens (human)
nucleusHeat shock cognate 71 kDa proteinHomo sapiens (human)
nucleoplasmS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
cytosolS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
extracellular exosomeS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
cytosolS-methyl-5'-thioadenosine phosphorylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID216972Minimum inhibitory conc. for 50% inhibition of Sindbis virus induced cytopathicity in Vero cells1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Carbocyclic oxetanocins lacking the C-3' methylene.
AID1310291Binding affinity to human truncated HSC70 NBD (1 to 381 residues) by SPR analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70.
AID239753Km against human methylthioadenosine phosphorylase expressed in Escherichia coli BL21 DE3 cells2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Design, synthesis, and biological evaluation of novel human 5'-deoxy-5'-methylthioadenosine phosphorylase (MTAP) substrates.
AID86482Minimum inhibitory conc. for 50% inhibition of coxsackie B4 virus induced cytopathicity in HeLa cells1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Carbocyclic oxetanocins lacking the C-3' methylene.
AID242855Kcat against human methylthioadenosine phosphorylase expressed in Escherichia coli BL21 DE3 cells2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Design, synthesis, and biological evaluation of novel human 5'-deoxy-5'-methylthioadenosine phosphorylase (MTAP) substrates.
AID216970Minimum inhibitory conc. for 50% inhibition of Reo-1 virus induced cytopathicity in Vero cells1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Carbocyclic oxetanocins lacking the C-3' methylene.
AID243020Ratio of Kcat to Km against human Methylthioadenosine phosphorylase2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Design, synthesis, and biological evaluation of novel human 5'-deoxy-5'-methylthioadenosine phosphorylase (MTAP) substrates.
AID179545GTP shift was determined in rat1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor.
AID31885Binding affinity to adenosine A1 receptor in rat brain membranes by measuring displacement of specific [3H]PIA as radioligand.1995Journal of medicinal chemistry, Mar-31, Volume: 38, Issue:7
Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.
AID32352Affinity for the Adenosine A1 receptor in the absence of GTP (A1-GTP) by using [3H]DPCPX as radioligand1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor.
AID216969Minimum inhibitory conc. for 50% inhibition of Parainfluenza-3 virus induced cytopathicity in Vero cells1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Carbocyclic oxetanocins lacking the C-3' methylene.
AID86357Minimum inhibitory conc. for 50% inhibition of Polio-1 virus induced cytopathicity in HeLa cells1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Carbocyclic oxetanocins lacking the C-3' methylene.
AID33337Binding affinity determined by displacement of specific binding of [125I]N-(4-amino-3-iodophenethyl)-adenosine in membranes of CHO cells stably transfected with the rat adenosine A3 receptor1995Journal of medicinal chemistry, Mar-31, Volume: 38, Issue:7
Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.
AID86484Minimum inhibitory conc. for 50% inhibition of vesicular stomatitis virus induced cytopathicity in HeLa cells1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Carbocyclic oxetanocins lacking the C-3' methylene.
AID32353Affinity for the Adenosine A1 receptor in the presence of GTP (A1+GTP) by using [3H]-DPCPX as radioligand1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor.
AID86481Minimum inhibitory conc. for 50% inhibition of alteration of morphology in HeLa cells1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Carbocyclic oxetanocins lacking the C-3' methylene.
AID33792Binding affinity to adenosine A2A receptor in rat striatal membranes by measuring displacement of specific [3H]-CGS- 21680 as radioligand1995Journal of medicinal chemistry, Mar-31, Volume: 38, Issue:7
Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.
AID216971Minimum inhibitory conc. for 50% inhibition of forest virus induced cytopathicity in Vero cells1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Carbocyclic oxetanocins lacking the C-3' methylene.
AID216973Minimum inhibitory conc. for 50% inhibition of alteration of morphology in Vero cells1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Carbocyclic oxetanocins lacking the C-3' methylene.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (63)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.59)18.7374
1990's12 (19.05)18.2507
2000's26 (41.27)29.6817
2010's16 (25.40)24.3611
2020's8 (12.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.23 (24.57)
Research Supply Index4.17 (2.92)
Research Growth Index5.73 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other62 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]